Cryoport, Inc. reported $186M of revenue over the trailing twelve months, +12% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $186M (to Q2 2026). Net income: −$37M, trailing twelve months to Q2 2026. Free cash flow: −$20M, trailing twelve months to Q2 2026. Operating margin: −21%, trailing twelve months to Q2 2026.

CYRXCryoport, Inc.

Industrials

$16.92+73% 1Y

$16.92

$7.7252 weeks$18.14

CYRX as reported

Cryoport, Inc. reported $186M of revenue over the trailing twelve months, +12% on the year before. 11 reported series are charted on this page, each one as filed.

$186M

Revenue, trailing twelve months · to Q2 2026 · +12% against the twelve months before

Net income: −$37M
Net income · −147% year on year · trailing twelve months to Q2 2026
Free cash flow: −$20M
Free cash flow · −41% year on year · trailing twelve months to Q2 2026
Operating margin: −21%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CYRX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$186M	+12%	Q2 2026
Net income	−$37M	−147%	Q2 2026
EPS	−$0.91	−165%	Q2 2026
Gross margin	47%	n/a	Q2 2026
Operating margin	−21%	n/a	Q2 2026
Net margin	−20%	n/a	Q2 2026
ROE	9.5%	n/a	Q2 2026
ROA	6.2%	n/a	Q2 2026
ROIC	175%	n/a	Q1 2025 · 5 quarters behind
Free cash flow	−$20M	−41%	Q2 2026
P/E	6.40	n/a	Q1 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.